Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-09-001782
Filing Date
2009-01-13
Accepted
2009-01-13 16:23:16
Documents
1
Period of Report
2009-01-11

Document Format Files

Seq Description Document Type Size
1 v136970_ex.html 4  
1 v136970_ex.xml 4 3642
  Complete submission text file 0001144204-09-001782.txt   5613
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address HAADMUR MEBUYON 26 HARNOT JERUSALEM L3 95403
Business Address 972 544 865 489
JACOB HAROLD (Reporting) CIK: 0001443692 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50298 | Film No.: 09524122